Even after completing treatment for tuberculosis (TB), some patients may remain vulnerable to further lung infections.

Introduction Interstitial lung disease (ILD) is a serious extra-articular manifestation of rheumatoid arthritis (RA) ...

The likelihood that a person with early-stage non-small cell lung cancer will receive curative treatment still varies ...

A data analysis found the inhaled therapy Tyvaso outperformed a placebo at preserving lung function in people with IPF in a ...

DLCO declined earliest, falling measurably about 10 years before the defined onset. By five years before onset, DLCO had ...

In idiopathic pulmonary fibrosis (IPF), the trajectory of declining lung function and clinical worsening was less drastic with the use of inhaled treprostinil (Tyvaso), the placeb ...

A team of researchers at VCU Massey Comprehensive Cancer Center has identified a new pathway through which mutations in the tumor suppressor p53 gene—found very frequently in human tumors—hijack DNA ...

Lauren Godden shares updates on her baby John’s progress as he reaches different milestones Lauren Godden Lauren Godden is sharing the story of her son, John, who was born with a congenital heart ...

Residual lung abnormalities were consistent with elevated epithelial injury biomarkers, profibrotic signaling. HealthDay News — Elevated epithelial injury biomarkers and profibrotic signaling are seen ...

Pulmonary function tests (PFTs), also called lung function tests, are some of the most important, but least understood, tools healthcare providers use to evaluate lung health. Though many people have ...